|
1
|
McKenna WG, Barnes MM, Kinsella TJ,
Rosenberg SA, Lack EE and Glatstein E: Combined modality treatment
of adult soft tissue sarcomas of the head and neck. Int J Radiat
Oncol Biol Phys. 13:1127–1133. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen X, Bahrami A, Pappo A, Easton J,
Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, et al:
Recurrent somatic structural variations contribute to tumorigenesis
in pediatric osteosarcoma. Cell Rep. 7:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan H, Zhu JH and Yao XQ: Knockdown of
long noncoding RNA PVT1 reverses multidrug resistance in colorectal
cancer cells. Mol Med Rep. 2018. View Article : Google Scholar
|
|
8
|
An Q, Zhou L and Xu N: Long noncoding RNA
FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer
by sponging miR-143. Biomed Pharmacother. 103:415–420. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Q, Chen F, Fei Z, Zhao J, Liang Y,
Pan W, Liu X and Zheng D: Genetic variants of lncRNA HOTAIR
contribute to the risk of osteosarcoma. Oncotarget. 7:19928–19934.
2016.PubMed/NCBI
|
|
10
|
Chen F, Mo J and Zhang L: Long noncoding
RNA BCAR4 promotes osteosarcoma progression through activating
GLI2-dependent gene transcription. Tumour Biol. 37:13403–13412.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
12
|
Li W, Xie P and Ruan WH: Overexpression of
lncRNA UCA1 promotes osteosarcoma progression and correlates with
poor prognosis. J Bone Oncol. 5:80–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pasmant E, Laurendeau I, Heron D, Vidaud
M, Vidaud D and Bieche I: Characterization of a germ-line deletion,
including the entire INK4/ARF locus, in a melanoma-neural system
tumor family: Identification of ANRIL, an antisense noncoding RNA
whose expression coclusters with ARF. Cancer Res. 67:3963–3969.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu W, Gius D, Onyango P, Muldoon-Jacobs K,
Karp J, Feinberg AP and Cui H: Epigenetic silencing of tumour
suppressor gene p15 by its antisense RNA. Nature. 451:202–206.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takayama K, Horie-Inoue K, Katayama S,
Suzuki T, Tsutsumi S, Ikeda K, Urano T, Fujimura T, Takagi K,
Takahashi S, et al: Androgen-responsive long noncoding RNA CTBP1-AS
promotes prostate cancer. EMBO J. 32:1665–1680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang X, Song JH, Cheng Y, Wu W, Bhagat T,
Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, et al: Long
non-coding RNA HNF1A-AS1 regulates proliferation and migration in
oesophageal adenocarcinoma cells. Gut. 63:881–890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han L, Kong R, Yin DD, Zhang EB, Xu TP, De
W and Shu YQ: Low expression of long noncoding RNA GAS6-AS1
predicts a poor prognosis in patients with NSCLC. Med Oncol.
30:6942013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong W, Yang L, Yu Q, Yao J and He A: A
new tumor suppressor lncRNA RP11-190D6.2 inhibits the
proliferation, migration, and invasion of epithelial ovarian cancer
cells. Onco Targets Ther. 10:1227–1235. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan H, Tong J, Lin X, Han Q and Huang H:
Effect of the WWOX gene on the regulation of the cell cycle and
apoptosis in human ovarian cancer stem cells. Mol Med Rep.
12:1783–1788. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie B, Zen Q, Wang X, He X, Xie Y, Zhang Z
and Li H: ACK1 promotes hepatocellular carcinoma progression via
downregulating WWOX and activating AKT signaling. Int J Oncol.
46:2057–2066. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nowakowska M, Pospiech K, Lewandowska U,
Piastowska-Ciesielska AW and Bednarek AK: Diverse effect of WWOX
overexpression in HT29 and SW480 colon cancer cell lines. Tumour
Biol. 35:9291–9301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li G, Sun L, Mu Z, Huang Y, Fu C and Hu B:
Ectopic WWOX expression inhibits growth of 5637 bladder cancer cell
in vitro and in vivo. Cell Biochem Biophys. 73:417–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang N, Jiang Z, Ren W, Yuan L and Zhu Y:
Association of polymorphisms in WWOX gene with risk and outcome of
osteosarcoma in a sample of the young Chinese population. Onco
Targets Ther. 9:807–813. 2016.PubMed/NCBI
|
|
24
|
Del Mare S and Aqeilan RI: Tumor
Suppressor WWOX inhibits osteosarcoma metastasis by modulating
RUNX2 function. Sci Rep. 5:129592015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jawad MU and Scully SP: In brief:
Classifications in brief: Enneking classification: Benign and
malignant tumors of the musculoskeletal system. Clin Orthop Relat
Res. 468:2000–2002. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang T, Li J, Yin F, Lin B, Wang Z, Xu J,
Wang H, Zuo D, Wang G, Hua Y and Cai Z: Toosendanin demonstrates
promising antitumor efficacy in osteosarcoma by targeting STAT3.
Oncogene. 36:6627–6639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu
Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine
integrated with chemotherapy for stage IV non-surgical gastric
cancer: A retrospective clinical analysis. J Integr Med.
15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mondal J, Das J, Shah R and Khuda-Bukhsh
AR: A homeopathic nosode, Hepatitis C 30 demonstrates anticancer
effect against liver cancer cells in vitro by modulating telomerase
and topoisomerase II activities as also by promoting apoptosis via
intrinsic mitochondrial pathway. J Integr Med. 14:209–218. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adaramoye O, Erguen B, Oyebode O, Nitzsche
B, Höpfner M, Jung K and Rabien A: Antioxidant, antiangiogenic and
antiproliferative activities of root methanol extract of Calliandra
portoricensis in human prostate cancer cells. J Integr Med.
13:185–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Wang N, Cheung F, Lao L, Li C and
Feng Y: Chinese medicines for prevention and treatment of human
hepatocellular carcinoma: Current progress on pharmacological
actions and mechanisms. J Integr Med. 13:142–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zang QQ, Zhang L, Gao N and Huang C:
Ophiopogonin D inhibits cell proliferation, causes cell cycle
arrest at G2/M, and induces apoptosis in human breast carcinoma
MCF-7 cells. J Integr Med. 14:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wahlestedt C: Natural antisense and
noncoding RNA transcripts as potential drug targets. Drug Discov
Today. 11:503–508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Faghihi MA and Wahlestedt C: Regulatory
roles of natural antisense transcripts. Nat Rev Mol Cell Biol.
10:637–643. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yelin R, Dahary D, Sorek R, Levanon EY,
Goldstein O, Shoshan A, Diber A, Biton S, Tamir Y, Khosravi R, et
al: Widespread occurrence of antisense transcription in the human
genome. Nat Biotechnol. 21:379–386. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kurek KC, Del Mare S, Salah Z, Abdeen S,
Sadiq H, Lee SH, Gaudio E, Zanesi N, Jones KB, DeYoung B, et al:
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma
is associated with increased tumorigenicity and aberrant RUNX2
expression. Cancer Res. 70:5577–5586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Del Mare S, Kurek KC, Stein GS, Lian JB
and Aqeilan RI: Role of the WWOX tumor suppressor gene in bone
homeostasis and the pathogenesis of osteosarcoma. Am J Cancer Res.
1:585–594. 2011.PubMed/NCBI
|
|
39
|
Zelzer E, Glotzer DJ, Hartmann C, Thomas
D, Fukai N, Soker S and Olsen BR: Tissue specific regulation of
VEGF expression during bone development requires Cbfa1/Runx2. Mech
Dev. 106:97–106. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pratap J, Javed A, Languino LR, van Wijnen
AJ, Stein JL, Stein GS and Lian JB: The Runx2 osteogenic
transcription factor regulates matrix metalloproteinase 9 in bone
metastatic cancer cells and controls cell invasion. Mol Cell Biol.
25:8581–8591. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang X, Manner PA, Horner A, Shum L, Tuan
RS and Nuckolls GH: Regulation of MMP-13 expression by RUNX2 and
FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage.
12:963–973. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lim M, Zhong C, Yang S, Bell AM, Cohen MB
and Roy-Burman P: Runx2 regulates survivin expression in prostate
cancer cells. Lab Invest. 90:222–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
van der Deen M, Akech J, Lapointe D, Gupta
S, Young DW, Montecino MA, Galindo M, Lian JB, Stein JL, Stein GS
and van Wijnen AJ: Genomic promoter occupancy of runt-related
transcription factor RUNX2 in osteosarcoma cells identifies genes
involved in cell adhesion and motility. J Biol Chem. 287:4503–4517.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Elbashir SM, Harborth J, Weber K and
Tuschl T: Analysis of gene function in somatic mammalian cells
using small interfering RNAs. Methods. 26:199–213. 2002. View Article : Google Scholar : PubMed/NCBI
|
